Lapalombella, R., Yu, B., Triantafillou, G., Liu, Q., Butchar, J. P., Lozanski, G., . . . Byrd, J. C. (2008). Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells. American Society of Hematology.
Citação norma ChicagoLapalombella, Rosa, et al. Lenalidomide Down-regulates the CD20 Antigen and Antagonizes Direct and Antibody-dependent Cellular Cytotoxicity of Rituximab On Primary Chronic Lymphocytic Leukemia Cells. American Society of Hematology, 2008.
Citação norma MLALapalombella, Rosa, et al. Lenalidomide Down-regulates the CD20 Antigen and Antagonizes Direct and Antibody-dependent Cellular Cytotoxicity of Rituximab On Primary Chronic Lymphocytic Leukemia Cells. American Society of Hematology, 2008.